je.st
news
Home
› Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin
Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin
2013-02-27 01:19:04| drugdiscoveryonline Home Page
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin
Tags: application
forward
drug
oral
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||